Skip to main content
Live · TradingView
Back to the NewsWire

Streetinsider

Published September 10, 2026 · Updated September 11, 2026

Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Plans Phase 2 Psilocybin ...

press release , visit https://nnw.fm/ZLlie. About Optimi Health Corp. Optimi Health Corp. is a commercial-stage pharmaceutical company focused on.

Read the full story at Streetinsider

Surfaced by this Google Alert

  • Psychedelic press release